Literature DB >> 24127424

The synthesis of methylated, phosphorylated, and phosphonated 3'-aminoacyl-tRNA(Sec) mimics.

Lukas Rigger1, Rachel L Schmidt, Kaitlyn M Holman, Miljan Simonović, Ronald Micura.   

Abstract

The twenty first amino acid, selenocysteine (Sec), is the only amino acid that is synthesized on its cognate transfer RNA (tRNA(Sec)) in all domains of life. The multistep pathway involves O-phosphoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS), an enzyme that catalyzes the terminal chemical reaction during which the phosphoseryl-tRNA(Sec) intermediate is converted into selenocysteinyl-tRNA(Sec). The SepSecS architecture and the mode of tRNA(Sec) recognition have been recently determined at atomic resolution. The crystal structure provided valuable insights that gave rise to mechanistic proposals that could not be validated because of the lack of appropriate molecular probes. To further improve our understanding of the mechanism of the biosynthesis of selenocysteine in general and the mechanism of SepSecS in particular, stable tRNA(Sec) substrates carrying aminoacyl moieties that mimic particular reaction intermediates are needed. Here, we report on the accurate synthesis of methylated, phosphorylated, and phosphonated serinyl-derived tRNA(Sec) mimics that contain a hydrolysis-resistant ribose 3'-amide linkage instead of the natural ester bond. The procedures introduced allow for efficient site-specific methylation and/or phosphorylation directly on the solid support utilized in the automated RNA synthesis. For the preparation of (S)-2-amino-4-phosphonobutyric acid-oligoribonucleotide conjugates, a separate solid support was generated. Furthermore, we developed a three-strand enzymatic ligation protocol to obtain the corresponding full-length tRNA(Sec) derivatives. Finally, we developed an electrophoretic mobility shift assay (EMSA) for rapid, qualitative characterization of the SepSecS-tRNA interactions. The novel tRNA(Sec) mimics are promising candidates for further elucidation of the biosynthesis of selenocysteine by X-ray crystallography and other biochemical approaches, and could be attractive for similar studies on other tRNA-dependent enzymes.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  RNA; RNA structures; amino acids; bioconjugation; solid-phase synthesis

Mesh:

Substances:

Year:  2013        PMID: 24127424      PMCID: PMC4010121          DOI: 10.1002/chem.201302188

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  27 in total

1.  Efficient access to nonhydrolyzable initiator tRNA based on the synthesis of 3'-azido-3'-deoxyadenosine RNA.

Authors:  Jessica Steger; Dagmar Graber; Holger Moroder; Anna-Skrollan Geiermann; Michaela Aigner; Ronald Micura
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-04       Impact factor: 15.336

2.  Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.

Authors:  Franziska Diezmann; Hendrik Eberhard; Oliver Seitz
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

3.  RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea.

Authors:  Jing Yuan; Sotiria Palioura; Juan Carlos Salazar; Dan Su; Patrick O'Donoghue; Michael J Hohn; Alexander Machado Cardoso; William B Whitman; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

Review 4.  Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.

Authors:  Harri Lönnberg
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

5.  The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation.

Authors:  Sotiria Palioura; R Lynn Sherrer; Thomas A Steitz; Dieter Söll; Miljan Simonovic
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

6.  Characterization of mammalian selenoproteomes.

Authors:  Gregory V Kryukov; Sergi Castellano; Sergey V Novoselov; Alexey V Lobanov; Omid Zehtab; Roderic Guigó; Vadim N Gladyshev
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

7.  Chemical characterization of the selenoprotein component of clostridial glycine reductase: identification of selenocysteine as the organoselenium moiety.

Authors:  J E Cone; R M Del Río; J N Davis; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

Review 8.  Synthesis and decoding of selenocysteine and human health.

Authors:  Rachel L Schmidt; Miljan Simonović
Journal:  Croat Med J       Date:  2012-12       Impact factor: 1.351

9.  Selective desulfurization significantly expands sequence variety of 3'-peptidyl-tRNA mimics obtained by native chemical ligation.

Authors:  Anna-Skrollan Geiermann; Ronald Micura
Journal:  Chembiochem       Date:  2012-07-11       Impact factor: 3.164

10.  Biosynthesis of selenocysteine on its tRNA in eukaryotes.

Authors:  Xue-Ming Xu; Bradley A Carlson; Heiko Mix; Yan Zhang; Kazima Saira; Richard S Glass; Marla J Berry; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS Biol       Date:  2007-01       Impact factor: 8.029

View more
  4 in total

1.  Structural asymmetry of the terminal catalytic complex in selenocysteine synthesis.

Authors:  Rachel L French; Nirupama Gupta; Paul R Copeland; Miljan Simonović
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

2.  Allyl group-containing polyvinylphosphonates as a flexible platform for the selective introduction of functional groups via polymer-analogous transformations.

Authors:  Kerstin Halama; Andreas Schaffer; Bernhard Rieger
Journal:  RSC Adv       Date:  2021-11-30       Impact factor: 3.361

3.  Synthesis of aminoacylated N(6),N(6)-dimethyladenosine solid support for efficient access to hydrolysis-resistant 3'-charged tRNA mimics.

Authors:  Sandro Neuner; Ronald Micura
Journal:  Bioorg Med Chem       Date:  2014-10-13       Impact factor: 3.641

4.  Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase.

Authors:  Anupama K Puppala; Rachel L French; Doreen Matthies; Ulrich Baxa; Sriram Subramaniam; Miljan Simonović
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.